References:
1. Bossone E, Eagle KA. Epidemiology and Management of Aortic Disease:
Aortic Aneurysms and Acute Aortic Syndromes. Nature reviews
Cardiology (2021) 18(5):331-48. Epub 2020/12/24. doi:
10.1038/s41569-020-00472-6.
2. Mutlu O, Salman HE, Al-Thani H, El-Menyar A, Qidwai UA, Yalcin HC.
How Does Hemodynamics Affect Rupture Tissue Mechanics in Abdominal
Aortic Aneurysm: Focus on Wall Shear Stress Derived Parameters,
Time-Averaged Wall Shear Stress, Oscillatory Shear Index, Endothelial
Cell Activation Potential, and Relative Residence Time. Computers
in biology and medicine (2023) 154:106609. Epub 2023/02/02. doi:
10.1016/j.compbiomed.2023.106609.
3. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht
H, et al. 2014 Esc Guidelines on the Diagnosis and Treatment of Aortic
Diseases: Document Covering Acute and Chronic Aortic Diseases of the
Thoracic and Abdominal Aorta of the Adult. The Task Force for the
Diagnosis and Treatment of Aortic Diseases of the European Society of
Cardiology (Esc). European heart journal (2014) 35(41):2873-926.
Epub 2014/09/01. doi: 10.1093/eurheartj/ehu281.
4. Gao J, Cao H, Hu G, Wu Y, Xu Y, Cui H, et al. The Mechanism and
Therapy of Aortic Aneurysms. Signal transduction and targeted
therapy (2023) 8(1):55. Epub 2023/02/04. doi:
10.1038/s41392-023-01325-7.
5. Golledge J. Abdominal Aortic Aneurysm: Update on Pathogenesis and
Medical Treatments. Nature reviews Cardiology (2019)
16(4):225-42. Epub 2018/11/18. doi: 10.1038/s41569-018-0114-9.
6. Scherlinger M, Richez C, Tsokos GC, Boilard E, Blanco P. The Role of
Platelets in Immune-Mediated Inflammatory Diseases. Nature reviews
Immunology (2023):1-16. Epub 2023/01/29. doi:
10.1038/s41577-023-00834-4.
7. McInnes IB, Gravallese EM. Immune-Mediated Inflammatory Disease
Therapeutics: Past, Present and Future. Nature reviews Immunology(2021) 21(10):680-6. Epub 2021/09/15. doi: 10.1038/s41577-021-00603-1.
8. Conrad N, Verbeke G, Molenberghs G, Goetschalckx L, Callender T,
Cambridge G, et al. Autoimmune Diseases and Cardiovascular Risk: A
Population-Based Study on 19 Autoimmune Diseases and 12 Cardiovascular
Diseases in 22 Million Individuals in the Uk. Lancet (London,
England) (2022) 400(10354):733-43. Epub 2022/08/31. doi:
10.1016/s0140-6736(22)01349-6.
9. Agca R, Smulders Y, Nurmohamed M. Cardiovascular Disease Risk in
Immune-Mediated Inflammatory Diseases: Recommendations for Clinical
Practice. Heart (British Cardiac Society) (2022) 108(1):73-9.
Epub 2021/03/07. doi: 10.1136/heartjnl-2019-316378.
10. Gisterå A, Hansson GK. The Immunology of Atherosclerosis.Nature reviews Nephrology (2017) 13(6):368-80. Epub 2017/04/11.
doi: 10.1038/nrneph.2017.51.
11. Schmidt J, Sunesen K, Kornum JB, Duhaut P, Thomsen RW. Predictors
for Pathologically Confirmed Aortitis after Resection of the Ascending
Aorta: A 12-Year Danish Nationwide Population-Based Cross-Sectional
Study. Arthritis research & therapy (2011) 13(3):R87. Epub
2011/06/17. doi: 10.1186/ar3360.
12. Shovman O, Tiosano S, Comaneshter D, Cohen AD, Amital H, Sherf M.
Aortic Aneurysm Associated with Rheumatoid Arthritis: A Population-Based
Cross-Sectional Study. Clinical rheumatology (2016)
35(11):2657-61. Epub 2016/08/10. doi: 10.1007/s10067-016-3372-0.
13. Pujades-Rodriguez M, Duyx B, Thomas SL, Stogiannis D, Rahman A,
Smeeth L, et al. Rheumatoid Arthritis and Incidence of Twelve Initial
Presentations of Cardiovascular Disease: A Population Record-Linkage
Cohort Study in England. PloS one (2016) 11(3):e0151245. Epub
2016/03/16. doi: 10.1371/journal.pone.0151245.
14. Wang SH, Chang YS, Liu CJ, Lai CC, Chen TJ, Chen WS. Incidence and
Risk Analysis of Aortic Aneurysm and Aortic Dissection among Patients
with Systemic Lupus Erythematosus: A Nationwide Population-Based Study
in Taiwan. Lupus (2014) 23(7):665-71. Epub 2014/02/21. doi:
10.1177/0961203314523868.
15. Guy A, Tiosano S, Comaneshter D, Tekes-Manova D, Shovman O, Cohen
AD, et al. Aortic Aneurysm Association with Sle - a Case-Control Study.Lupus (2016) 25(9):959-63. Epub 2016/01/27. doi:
10.1177/0961203316628999.
16. Khalid U, Egeberg A, Ahlehoff O, Smedegaard L, Gislason GH, Hansen
PR. Nationwide Study on the Risk of Abdominal Aortic Aneurysms in
Patients with Psoriasis. Arteriosclerosis, thrombosis, and
vascular biology (2016) 36(5):1043-8. Epub 2016/04/16. doi:
10.1161/atvbaha.116.307449.
17. Chiu HY, Lo PC, Huang WF, Tsai YW, Tsai TF. Increased Risk of Aortic
Aneurysm (Aa) in Relation to the Severity of Psoriasis: A National
Population-Based Matched-Cohort Study. Journal of the American
Academy of Dermatology (2016) 75(4):747-54. Epub 2016/07/31. doi:
10.1016/j.jaad.2016.06.002.
18. Talathi S, Mannion M, Colvin E, Beck A, Dabal R, Maclin J, et al.
Aortitis with an Aneurysm at Initial Presentation of Crohn Disease.Journal of pediatric gastroenterology and nutrition (2018)
67(1):e12-e3. Epub 2018/06/22. doi: 10.1097/mpg.0000000000001945.
19. Taddio A, Maschio M, Martelossi S, Barbi E, Ventura A. Crohn’s
Disease and Takayasu’s Arteritis: An Uncommon Association. World
journal of gastroenterology (2013) 19(35):5933-5. Epub 2013/10/15. doi:
10.3748/wjg.v19.i35.5933.
20. Kashima K, Kawasaki D, Yotsumoto G, Hatake S, Yamashita E, Nagayoshi
S, et al. Rapid Progression of Aortic Regurgitation with Thoracic Aortic
Aneurysm Due to Takayasu Arteritis Associated with Ulcerative Colitis.Internal medicine (Tokyo, Japan) (2010) 49(11):1007-11. Epub
2010/06/04. doi: 10.2169/internalmedicine.49.3122.
21. Haug ES, Skomsvoll JF, Jacobsen G, Halvorsen TB, Saether OD, Myhre
HO. Inflammatory Aortic Aneurysm Is Associated with Increased Incidence
of Autoimmune Disease. Journal of vascular surgery (2003)
38(3):492-7. Epub 2003/08/30. doi: 10.1016/s0741-5214(03)00340-9.
22. Tin A, Köttgen A. Mendelian Randomization Analysis as a Tool to Gain
Insights into Causes of Diseases: A Primer. Journal of the
American Society of Nephrology : JASN (2021) 32(10):2400-7. Epub
2021/06/18. doi: 10.1681/asn.2020121760.
23. Gupta V, Walia GK, Sachdeva MP. ’Mendelian Randomization’: An
Approach for Exploring Causal Relations in Epidemiology. Public
health (2017) 145:113-9. Epub 2017/04/01. doi:
10.1016/j.puhe.2016.12.033.
24. Boef AG, Dekkers OM, le Cessie S. Mendelian Randomization Studies: A
Review of the Approaches Used and the Quality of Reporting.International journal of epidemiology (2015) 44(2):496-511. Epub
2015/05/09. doi: 10.1093/ije/dyv071.
25. Zheng J, Baird D, Borges MC, Bowden J, Hemani G, Haycock P, et al.
Recent Developments in Mendelian Randomization Studies. Current
epidemiology reports (2017) 4(4):330-45. Epub 2017/12/12. doi:
10.1007/s40471-017-0128-6.
26. Ha E, Bae SC, Kim K. Large-Scale Meta-Analysis across East Asian and
European Populations Updated Genetic Architecture and Variant-Driven
Biology of Rheumatoid Arthritis, Identifying 11 Novel Susceptibility
Loci. Annals of the rheumatic diseases (2021) 80(5):558-65. Epub
2020/12/15. doi: 10.1136/annrheumdis-2020-219065.
27. Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P, Behrens
TW, et al. Genetic Association Analyses Implicate Aberrant Regulation of
Innate and Adaptive Immunity Genes in the Pathogenesis of Systemic Lupus
Erythematosus. Nature genetics (2015) 47(12):1457-64. Epub
2015/10/27. doi: 10.1038/ng.3434.
28. Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM,
Swanson SA, et al. Strengthening the Reporting of Observational Studies
in Epidemiology Using Mendelian Randomization: The Strobe-Mr Statement.Jama (2021) 326(16):1614-21. Epub 2021/10/27. doi:
10.1001/jama.2021.18236.
29. Jansen H, Samani NJ, Schunkert H. Mendelian Randomization Studies in
Coronary Artery Disease. European heart journal (2014)
35(29):1917-24. Epub 2014/06/12. doi: 10.1093/eurheartj/ehu208.
30. Staley JR, Blackshaw J, Kamat MA, Ellis S, Surendran P, Sun BB, et
al. Phenoscanner: A Database of Human Genotype-Phenotype Associations.Bioinformatics (Oxford, England) (2016) 32(20):3207-9. Epub
2016/06/19. doi: 10.1093/bioinformatics/btw373.
31. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al.
The Mr-Base Platform Supports Systematic Causal Inference across the
Human Phenome. eLife (2018) 7. Epub 2018/05/31. doi:
10.7554/eLife.34408.
32. Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis
SJ, et al. Physical Activity and Risks of Breast and Colorectal Cancer:
A Mendelian Randomisation Analysis. Nature communications (2020)
11(1):597. Epub 2020/02/01. doi: 10.1038/s41467-020-14389-8.
33. Lin Z, Deng Y, Pan W. Combining the Strengths of Inverse-Variance
Weighting and Egger Regression in Mendelian Randomization Using a
Mixture of Regressions Model. PLoS genetics (2021)
17(11):e1009922. Epub 2021/11/19. doi: 10.1371/journal.pgen.1009922.
34. Bowden J, Del Greco MF, Minelli C, Zhao Q, Lawlor DA, Sheehan NA, et
al. Improving the Accuracy of Two-Sample Summary-Data Mendelian
Randomization: Moving Beyond the Nome Assumption. International
journal of epidemiology (2019) 48(3):728-42. Epub 2018/12/19. doi:
10.1093/ije/dyy258.
35. Verbanck M, Chen CY, Neale B, Do R. Detection of Widespread
Horizontal Pleiotropy in Causal Relationships Inferred from Mendelian
Randomization between Complex Traits and Diseases. Nature
genetics (2018) 50(5):693-8. Epub 2018/04/25. doi:
10.1038/s41588-018-0099-7.
36. Bowden J, Davey Smith G, Burgess S. Mendelian Randomization with
Invalid Instruments: Effect Estimation and Bias Detection through Egger
Regression. International journal of epidemiology (2015)
44(2):512-25. Epub 2015/06/08. doi: 10.1093/ije/dyv080.
37. Werner N, Nickenig G, Sinning JM. Complex Pci Procedures: Challenges
for the Interventional Cardiologist. Clinical research in
cardiology : official journal of the German Cardiac Society (2018)
107(Suppl 2):64-73. Epub 2018/07/07. doi: 10.1007/s00392-018-1316-1.
38. Björck M, Wanhainen A. Pathophysiology of Aaa: Heredity Vs
Environment. Progress in cardiovascular diseases (2013)
56(1):2-6. Epub 2013/09/03. doi: 10.1016/j.pcad.2013.05.003.
39. Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton
T, et al. Risk Thresholds for Alcohol Consumption: Combined Analysis of
Individual-Participant Data for 599 912 Current Drinkers in 83
Prospective Studies. Lancet (London, England) (2018)
391(10129):1513-23. Epub 2018/04/21. doi: 10.1016/s0140-6736(18)30134-x.
40. Ananthakrishnan AN, Kaplan GG, Bernstein CN, Burke KE, Lochhead PJ,
Sasson AN, et al. Lifestyle, Behaviour, and Environmental Modification
for the Management of Patients with Inflammatory Bowel Diseases: An
International Organization for Study of Inflammatory Bowel Diseases
Consensus. The lancet Gastroenterology & hepatology (2022)
7(7):666-78. Epub 2022/04/30. doi: 10.1016/s2468-1253(22)00021-8.
41. Pujades-Rodriguez M, Morgan AW, Cubbon RM, Wu J. Dose-Dependent Oral
Glucocorticoid Cardiovascular Risks in People with Immune-Mediated
Inflammatory Diseases: A Population-Based Cohort Study. PLoS
medicine (2020) 17(12):e1003432. Epub 2020/12/04. doi:
10.1371/journal.pmed.1003432.
42. Rasmussen TE, Hallett JW, Jr., Metzger RL, Richardson DM, Harmsen
WS, Goronzy JJ, et al. Genetic Risk Factors in Inflammatory Abdominal
Aortic Aneurysms: Polymorphic Residue 70 in the Hla-Dr B1 Gene as a Key
Genetic Element. Journal of vascular surgery (1997) 25(2):356-64.
Epub 1997/02/01. doi: 10.1016/s0741-5214(97)70358-6.
43. Sakata N, Tashiro T, Uesugi N, Kawara T, Furuya K, Hirata Y, et al.
Igg4-Positive Plasma Cells in Inflammatory Abdominal Aortic Aneurysm:
The Possibility of an Aortic Manifestation of Igg4-Related Sclerosing
Disease. The American journal of surgical pathology (2008)
32(4):553-9. Epub 2008/02/28. doi: 10.1097/PAS.0b013e31815a04db.
44. Ollier B. Shock Revelations About Hla-Dr4 – a Shortcut to
Rheumatoid Arthritis? Nature medicine (1996) 2(3):279-80. Epub
1996/03/01. doi: 10.1038/nm0396-279.
45. Ali AA, Khalid KE, Mohammed SE, Akhtar MS, Saeed OK. Association of
Human Leukocyte Antigen (Hla) Class Ii (Drb1 and Dqb1) Alleles and
Haplotypes with Rheumatoid Arthritis in Sudanese Patients.Frontiers in immunology (2023) 14:1178546. Epub 2023/07/10. doi:
10.3389/fimmu.2023.1178546.
46. Atouf O, Benbouazza K, Brick C, Bzami F, Bennani N, Amine B, et al.
Hla Polymorphism and Early Rheumatoid Arthritis in the Moroccan
Population. Joint bone spine (2008) 75(5):554-8. Epub 2008/09/20.
doi: 10.1016/j.jbspin.2008.01.027.
47. Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, et al.
Hla-Drb1 Genotype Associations in 793 White Patients from a Rheumatoid
Arthritis Inception Cohort: Frequency, Severity, and Treatment Bias.Arthritis and rheumatism (2002) 46(9):2320-9. Epub 2002/10/02.
doi: 10.1002/art.10485.
48. Yang M, Kuang X, Li J, Pan Y, Tan M, Lu B, et al. Meta-Analysis of
the Association of Hla-Drb1 with Rheumatoid Arthritis in Chinese
Populations. BMC musculoskeletal disorders (2013) 14:307. Epub
2013/10/29. doi: 10.1186/1471-2474-14-307.
49. Benham H, Nel HJ, Law SC, Mehdi AM, Street S, Ramnoruth N, et al.
Citrullinated Peptide Dendritic Cell Immunotherapy in Hla Risk
Genotype-Positive Rheumatoid Arthritis Patients. Science
translational medicine (2015) 7(290):290ra87. Epub 2015/06/05. doi:
10.1126/scitranslmed.aaa9301.